It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lysine lactylation (Kla) links metabolism and gene regulation and plays a key role in multiple biological processes. However, the regulatory mechanism and functional consequence of Kla remain to be explored. Here, we report that HBO1 functions as a lysine lactyltransferase to regulate transcription. We show that HBO1 catalyzes the addition of Kla in vitro and intracellularly, and E508 is a key site for the lactyltransferase activity of HBO1. Quantitative proteomic analysis further reveals 95 endogenous Kla sites targeted by HBO1, with the majority located on histones. Using site-specific antibodies, we find that HBO1 may preferentially catalyze histone H3K9la and scaffold proteins including JADE1 and BRPF2 can promote the enzymatic activity for histone Kla. Notably, CUT&Tag assays demonstrate that HBO1 is required for histone H3K9la on transcription start sites (TSSs). Besides, the regulated Kla can promote key signaling pathways and tumorigenesis, which is further supported by evaluating the malignant behaviors of HBO1- knockout (KO) tumor cells, as well as the level of histone H3K9la in clinical tissues. Our study reveals HBO1 serves as a lactyltransferase to mediate a histone Kla-dependent gene transcription.
The regulatory mechanism and functional consequence of lysine lactylation remain to be explored. Here, the authors identify HBO1 as a lysine lactyltransferase and suggest a potential role of HBO1 in tumorigenesis through H3K9la-mediated transcription regulation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Wang, Siyu 1 ; Lu, Congcong 2 ; Wu, Zhiyue 1 ; Wang, Aiyuan 1 ; Mo, Jing 3 ; Zhang, Jianji 1 ; Han, Yanpu 1 ; Yuan, Ye 4 ; Zhang, Yingao 1 ; Zang, Yong 1 ; He, Chaoran 1 ; Bai, Xue 1 ; Tian, Shanshan 1 ; Zhai, Guijin 1 ; Wu, Xudong 4
; Zhang, Kai 5
1 School of Basic Medical Sciences, Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
2 College of Life Sciences, Nankai University, Frontiers Science Center for Cell Responses, Tianjin, China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032)
3 Tianjin Medical University, Department of Pathology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
4 School of Basic Medical Sciences, Tianjin Medical University, Department of Cell Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
5 School of Basic Medical Sciences, Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University Eye Hospital, Tianjin Medical University, Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute and School of Optometry, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)




